Vanguard Group Inc

13F Holdings History for RHYTHM PHARMACEUTICALS, INC. - COM (RYTM)

Symbol: RYTM on Nasdaq
Investment type: Equity / COM
Latest Disclosed Ownership: 5M shares
Security Ownership: 7.52%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in RHYTHM PHARMACEUTICALS, INC. COM (RYTM)

2025-10-30 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5M shares of RHYTHM PHARMACEUTICALS, INC. COM (RYTM). This represents 7.52% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	7.52%		$505M	5M			$100.99	13G/A	9/30/2025	30 Oct 2025 15:50:03

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	+0%	$505M	5M	+1,407,313	+39.2%	$100.99	Q3 2025
6/30/2025	0%	+0%	$227M	3.59M	+144,188	+4.19%	$63.19	Q2 2025
3/31/2025	0%	+0%	$182M	3.44M	+2,326		$52.97	Q1 2025
12/31/2024	0%	0%	$193M	3.44M	-5,311	-0.15%	$55.98	Q4 2024
9/30/2024	0%	+0%	$181M	3.45M	+87,216	+2.6%	$52.39	Q3 2024
6/30/2024	0%	+0%	$138M	3.36M	+56,549	+1.71%	$41.06	Q2 2024
3/31/2024	0%	+0%	$143M	3.3M	+77,208	+2.39%	$43.33	Q1 2024
12/31/2023	0%	+0%	$148M	3.23M	+212,370	+7.04%	$45.97	Q4 2023
9/30/2023	0%	+0%	$69.1M	3.01M	+85,139	+2.91%	$22.93	Q3 2023
6/30/2023	0%	+0%	$48.3M	2.93M	+281,293	+10.6%	$16.49	Q2 2023
3/31/2023	0%	+0%	$47.2M	2.65M	+51,822	+2%	$17.84	Q1 2023
12/31/2022	0%	+0%	$75.6M	2.6M	+362,042	+16.2%	$29.12	Q4 2022
9/30/2022	0%	+0%	$54.7M	2.23M	+84,546	+3.93%	$24.50	Q3 2022
6/30/2022	0%	0%	$8.92M	2.15M	-107,294	-4.75%	$4.15	Q2 2022
3/31/2022	0%	0%	$26M	2.26M	-66,501	-2.86%	$11.52	Q1 2022
12/31/2021	0%	+0%	$23.2M	2.32M	+10,443	+0.45%	$9.98	Q4 2021
9/30/2021	0%	+0%	$30.2M	2.31M	+55,656	+2.47%	$13.06	Q3 2021
6/30/2021	0%	+0%	$44.2M	2.26M	+5,027	+0.22%	$19.58	Q2 2021
3/31/2021	0%	+0%	$47.9M	2.25M	+366,871	+19.5%	$21.27	Q1 2021
12/31/2020	0%	0%	$56.1M	1.89M	-5,514	-0.29%	$29.73	Q4 2020
9/30/2020	0%	0%	$41M	1.89M	-79,985	-4.06%	$21.67	Q3 2020
6/30/2020	0%	+0%	$44M	1.97M	+260,210	+15.2%	$22.30	Q2 2020
3/31/2020	0%	+0%	$26M	1.71M	+31,340	+1.87%	$15.22	Q1 2020
12/31/2019	0%	+0%	$38.6M	1.68M	+400,194	+31.3%	$22.96	Q4 2019
9/30/2019	0%	+0%	$27.6M	1.28M	+92,019	+7.75%	$21.59	Q3 2019
6/30/2019	0%	+0%	$26.1M	1.19M	+35,270	+3.06%	$22.00	Q2 2019
3/31/2019	0%	+0%	$31.6M	1.15M	+69,525	+6.42%	$27.41	Q1 2019
12/31/2018	0%	+0%	$29.1M	1.08M	+34,279	+3.27%	$26.88	Q4 2018
9/30/2018	0%	+0%	$30.6M	1.05M	+115,177	+12.3%	$29.17	Q3 2018
6/30/2018	0%	+0%	$29.2M	933K	+530,097	+132%	$31.26	Q2 2018
3/31/2018	0%	0%	$8.02M	403K	-74,521	-15.6%	$19.90	Q1 2018
12/31/2017	0%	+0%	$13.9M	477K	+477,433	NEW	$29.06	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.